SCHEMBL3614902

SCHEMBL3614902

CCOP(C)(=O)CCC=O

nearest known ligand 0.49

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
AOX1 Q06278 1/20 0.49
TSHR P16473 4/20 0.40
TP53 P04637 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
PPARD Q03181 2/20 0.37
ALDH1A1 P00352 1/20 0.36
KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3625004 0.83 ALDH1A1 (0.39) AOX1TSHRALDH1A1
SCHEMBL3623029 0.79 CYP3A4 (0.48) AOX1TSHRALDH1A1
SCHEMBL2382808 0.79 PPARD (0.54) AOX1TSHRTP53TDP1PPARD
SCHEMBL9712303 0.77 ALDH1A1 (0.43) AOX1ALDH1A1
SCHEMBL3623920 0.77 AOX1 (0.34) AOX1
SCHEMBL3623160 0.76
SCHEMBL923145 0.76
SCHEMBL2173898 0.76 AOX1 (0.47) AOX1TSHRTP53TDP1PPARD
SCHEMBL575221 0.75
SCHEMBL6066224 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114085244-B Preparation method of 4- (hydroxymethyl phosphono) -2-carbonyl butyric acid 浙江新安化工集团股份有限公司 2024-02-02 CN claimed
WO-2024171095-A1 A PROCESS FOR PREPARATION OF GLUFOSINATE OR ISOMER OR SALT THEREOF UPL LIMITED (IN) 2024-08-22 WO disclosed
US-9139604-B2 Antiviral phosphonate analogs GILEAD SCIENCES, INC. (US) 2015-09-22 US disclosed
US-20150025039-A1 ANTIVIRAL PHOSPHONATE ANALOGS GILEAD SCIENCES, INC. 2015-01-22 US disclosed
US-8871785-B2 Antiviral phosphonate analogs GILEAD SCIENCES, INC. (US) 2014-10-28 US disclosed
CN-101516898-B Method for producing phosphorus-containing alpha-amino acid and production intermediate therefor MEIJI SEIKA KAISHA 2013-07-10 CN disclosed
US-20110288053-A1 ANTIVIRAL PHOSPHONATE ANALOGS GILEAD SCIENCES, INC. (US) 2011-11-24 US disclosed
US-20110071101-A1 Nucleoside Phosphonate Analogs BOOJAMRA CONSTANTINE G 2011-03-24 US disclosed
US-7795464-B2 Method for producing α-amino acid including phosphorus and production intermediates thereof MEIJI SEIKA KAISHA LTD. (JP) 2010-09-14 US disclosed
US-20090270647-A1 METHOD FOR PRODUCING ALPHA - AMINO ACID INCLUDING PHOSPHORUS AND PRODUCTION INTERMEDIATES THEREOF MEIJI SEIKA KAISHA LTD. (JP) 2009-10-29 US disclosed
CN-101516898-A Method for producing phosphorus-containing alpha-amino acid and production intermediate therefor MEIJI SEIKA KAISHA (JP) 2009-08-26 CN disclosed
EP-2065391-A1 METHOD FOR PRODUCING PHOSPHORUS-CONTAINING -AMINO ACID AND PRODUCTION INTERMEDIATE THEREOF MEIJI SEIKA KAISHA LTD. (JP) 2009-06-03 EP disclosed
EP-0350630-B1 PROCESS FOR THE PREPARATION OF N-ACYL-PHOSPHINOTHRICIN-P-ESTERS HOECHST AKTIENGESELLSCHAFT (DE) 1992-08-19 EP disclosed
EP-0350630-A1 Process for the preparation of N-acyl-phosphinothricin-P-esters HOECHST AKTIENGESELLSCHAFT (DE) 1990-01-17 EP disclosed
EP-0009022-B1 PROCESSES FOR PREPARING D,L-2-AMINO-4((HYDROXY)(METHYL)PHOSPHINOYL)-BUTYRIC ACID AND AN ACETAL OF AN ESTER OF 3-OXOPROPYLMETHYL PHOSPHINIC ACID MEIJI SEIKA KAISHA LTD. (JP) 1982-07-07 EP disclosed
US-4264532-A REACTING A DIALKYL PHOSPHONITE WITH ACROLEIN; ESTERIFING AND THEN REACTING WITH POTASSIUM CYANIDE AND AMMONIUM CHLORIDE MEIJI SEIKA KAISHA LTD. (JP) 1981-04-28 US disclosed
EP-0009022-A1 Processes for preparing D,L-2-amino-4((hydroxy)(methyl)phosphinoyl)-butyric acid and an acetal of an ester of 3-oxopropylmethyl phosphinic acid MEIJI SEIKA KAISHA LTD. (JP) 1980-03-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150025039-A1 ANTIVIRAL PHOSPHONATE ANALOGS TYMP, ITPA, PNP AOX1 4566/4885TSHR 4568/4885TP53 946/4885
US-20090270647-A1 METHOD FOR PRODUCING ALPHA - AMINO ACID INCLUDING PHOSPHORUS AND PRODUCTION INTERMEDIATES THEREOF BCAT1, BCAT2, DAO AOX1 693/4885TSHR 3946/4885TP53 2812/4885
US-20110071101-A1 Nucleoside Phosphonate Analogs TYMP, PNP, NUDT1 AOX1 3768/4885TSHR 3423/4885TP53 1353/4885
US-20110288053-A1 ANTIVIRAL PHOSPHONATE ANALOGS TYMP, ITPA, PNP AOX1 4566/4885TSHR 4568/4885TP53 946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.